MedPath

A clinical trial to study the effects of Tulsi (Holy basil) on immune status of healthy human subjects

Phase 2
Completed
Registration Number
CTRI/2009/091/000350
Lead Sponsor
Immunomodulatory trial is sponsered by CCRAS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Apparently healthy, volunteers, adult males or females aged between 18 and 60 years of age with no chronic illness. Not on any regular medication for the last one month.

Exclusion Criteria

A history of coronary heart disease or stroke, HIV, TB, Diabetes any other chronic disease, pregnant and lactating women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath